XORTX Therapeutics (XRTX) Interest Coverage Ratio (2020 - 2023)
XORTX Therapeutics' (XRTX) quarterly Interest Coverage Ratio came in at 982.7 in Q1 2023, up 9.4% YoY from 898.25 in Q1 2022, and down 3350.92% on a QoQ basis from 28.48 in Q4 2022.
XORTX Therapeutics (XRTX) Interest Coverage Ratio (2020 - 2023) Analysis & Trends
XORTX Therapeutics (XRTX) has 4 years of Interest Coverage Ratio data on file, last reported at 982.7 in Q1 2023.
- Quarterly Interest Coverage Ratio rose 9.4% year-over-year to 982.7 in Q1 2023, while the trailing twelve-month figure through Mar 2026 was 1.052142055511294e+18 (up 140.12% YoY) and the FY2025 annual result came in at 62.44, down 138.52% from the prior year.
- Interest Coverage Ratio retreated to 982.7 in Q1 2023, from 28.48 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1302.42 in Q2 2021 to a low of 1084.69 in Q1 2022.
- A 4-year average of 55.79 and a median of 24.87 in 2022 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 87.71% in 2022, down 364.31% in 2022.
- Tracing XRTX's Interest Coverage Ratio over 4 years: stood at 584.84 in 2020, then slumped by 139.63% to 231.77 in 2021, then soared by 87.71% to 28.48 in 2022, then tumbled by 3350.92% to 982.7 in 2023.
- The last three Interest Coverage Ratio figures came in at 982.7 (Q1 2023), 28.48 (Q4 2022), and 24.87 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 1.42 |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -14.59 |
| Mar 31, 2023 | -982.70 |
| Dec 31, 2022 | -28.48 |
| Sep 30, 2022 | -24.87 |
| Jun 30, 2022 | -81.50 |
| Mar 31, 2022 | -1,084.69 |
| Dec 31, 2021 | -231.77 |
| Sep 30, 2021 | 293.96 |
| Jun 30, 2021 | 1,302.42 |
| Mar 31, 2021 | 410.38 |
| Dec 31, 2020 | 584.84 |
| Sep 30, 2020 | 456.11 |